Notices. Notice
217 words·~1 min read·
/register/2004/04/13/04-8252A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2003N-0424] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Substantial Evidence of Effectiveness of New Animal Drugs AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is announcing that a collection of information entitled “Substantial Evidence of Effectiveness of New Animal Drugs”, has been approved by the Office of Management and Budget
(OMB)under provisions of the Paperwork Reduction Act of 1995 (the PRA). FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Management Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1472 SUPPLEMENTARY INFORMATION: In the **Federal Register** of January 7, 2004 (69 FR 923), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under section 3507 of the PRA (44 U.S.C. 3507). An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0356. The approval expires on March 31, 2007. Dated: April 6, 2004. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 04-8252 Filed 4-12-04; 8:45 am]
Connectionstraces to 1
Traces to 1 document